International Business Times: Scientists Find Harmless Strain of E.Coli Bacteria Provides Protection Against its Lethal Cousin
UC researchers hope to find a treatment for Hamburger E.coli
A new study by researchers from the University of Cincinnati College of Medicine offers evidence that a harmless strain of E.coli bacteria may offer protection from a lethal one. According to the study, Nissle—a strain of E.Coli that is used as a probiotic was found to protect human intestinal organoids (HIOs) from a pathogenic strain known as enterohemorrhagic E. coli or more commonly as hamburger E.coli. Alison Weiss, PhD, professor, and Suman Pradhan, PhD, research associate, both in the UC Department of Molecular Genetics, Biochemistry and Microbiology were authors of the study.
Read the full interview in International Business Times
Learn more about the research of Dr. Weiss and Dr. Pradhan.
Other media also covered the research findings and they include:
Featured photo of hamburgers courtesy of Unsplash.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.